SCHEMBL4968867

SCHEMBL4968867

C[C@H](NC(=O)O)[C@H](O[Si](C)(C)C(C)(C)C)C(=O)c1cccc(F)c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 2/20 0.39
RAB9A P51151 2/20 0.39
CHRNB2 P17787 1/20 0.39
SLC6A2 P23975 1/20 0.39
CHRNB4 P30926 1/20 0.39
CHRNA3 P32297 1/20 0.39
CHRNA4 P43681 1/20 0.39
SLC6A3 Q01959 1/20 0.39
HTT P42858 1/20 0.39
CYP1A2 P05177 1/20 0.39
CYP2C19 P33261 1/20 0.39
CES2 O00748 2/20 0.39
CES1 P23141 2/20 0.39
CTSL P07711 1/20 0.38
LMNA P02545 3/20 0.38
ALDH1A1 P00352 3/20 0.38
GAA P10253 2/20 0.38
GPR139 Q6DWJ6 1/20 0.38
ADRB2 P07550 1/20 0.36
ADRB1 P08588 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4982092 0.91 CHRNB2 (0.39) NPC1RAB9ACHRNB2SLC6A2CHRNB4
SCHEMBL5132720 0.82 CHRNA1 (0.38) CHRNB2SLC6A2CHRNB4CHRNA3CHRNA4
SCHEMBL5126877 0.82 ACACB (0.34) ALDH1A1GRM5
SCHEMBL4993919 0.76 CYP26A1 (0.39) CES2CES1LMNAALDH1A1GAA
SCHEMBL16164152 0.73 CES2 (0.51) NPC1RAB9ACHRNB2SLC6A2CHRNB4
SCHEMBL8101790 0.72 CES2 (0.43) NPC1RAB9ACHRNB2SLC6A2CHRNB4
SCHEMBL2175747 0.72 CTSS (0.42) NPC1RAB9AHTTLMNAALDH1A1
SCHEMBL3642856 0.69
SCHEMBL5165541 0.68
SCHEMBL3304599 0.68

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1971598-A1 BETA-SECRETASE MODULATORS AND METHODS OF USE Amgen Inc. (US) 2008-09-24 EP disclosed
WO-2007061670-A1 BETA-SECRETASE MODULATORS AND METHODS OF USE AMGEN INC. (US) 2007-05-31 WO disclosed